Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 31, 2006

Dyax and ZymoGenetics Ink Library License Agreement

  • ZymoGenetics will use Dyax’ antibody phage display libraries to discover therapeutic antibodies according to a nonexclusive license.

    ZymoGenetics also received sublicenses to relevant third-party antibody phage display patents that may be used with Dyax’ antibody phage display technology. Under the terms of the agreement, Dyax will receive upfront and annual technology license fees, clinical milestone payments, and royalties on net sales of products that may result from this transaction.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »